AiCure

📍 New York, United States🗓 Founded 2010👥 74 employees💰 Last funded Jul 2022
Software Development🌐 aicure.com
Website LinkedIn
AiCure is an AI and advanced data analytics company that monitors patient behavior and enables remote patient engagement in clinical trials. AiCure improves predictability of study timelines, reduces costs and accelerates timelines through remote patient engagement and assessments, including measuring digital biomarkers and real-time monitoring of patient dosing. Founded in 2010 and funded by the National Institutes of Health (NIH) and leading institutional investors, AiCure has more than 65 issued patents and works with global clients in over 30 countries. AiCure is globally recognized and is a recipient of the Scrip Award, AI 100 and Digital Health 150. For more information, please visit www.aicure.com.
7
Total investors
0
Early stage
2
Mid stage
4
Late stage
2010
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
7
Investor activity2015–2022 · investors recorded per year
2015220161201922020120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in AiCure?
AiCure has 7 investors on record on gritt.io, 2 mid-stage and 4 late-stage investors.
When did AiCure last raise funding?
The most recent investment in AiCure recorded on gritt.io was in July 2022.
When was AiCure founded?
AiCure was founded in 2010.
What industry is AiCure in?
AiCure operates in Software Development. Find similar Software Development investors on gritt.io.
Where is AiCure based?
AiCure is headquartered in New York, United States.